Cargando…

Mitochondrial dysfunction and consequences in calpain-3-deficient muscle

BACKGROUND: Nonsense or loss-of-function mutations in the non-lysosomal cysteine protease calpain-3 result in limb-girdle muscular dystrophy type 2A (LGMD2A). While calpain-3 is implicated in muscle cell differentiation, sarcomere formation, and muscle cytoskeletal remodeling, the physiological basi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahnke, Vanessa E., Peterson, Jennifer M., Van Der Meulen, Jack H., Boehler, Jessica, Uaesoontrachoon, Kitipong, Johnston, Helen K., Defour, Aurelia, Phadke, Aditi, Yu, Qing, Jaiswal, Jyoti K., Nagaraju, Kanneboyina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730798/ https://www.ncbi.nlm.nih.gov/pubmed/33308300 http://dx.doi.org/10.1186/s13395-020-00254-1

Ejemplares similares

Effects of Dantrolene Therapy on Disease Phenotype in Dystrophin Deficient mdx Mice
por: Quinn, James L, et al.
Publicado: (2013)

Annexin A1 Deficiency does not Affect Myofiber Repair but Delays Regeneration of Injured Muscles
por: Leikina, Evgenia, et al.
Publicado: (2015)

Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model
por: Jahnke, Vanessa E, et al.
Publicado: (2012)

Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B
por: Hogarth, Marshall W., et al.
Publicado: (2019)

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy
por: Vila, Maria C, et al.
Publicado: (2017)

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy
por: Yu, Qing, et al.
Publicado: (2013)

The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice
por: Sali, Arpana, et al.
Publicado: (2013)

Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice
por: Ziemba, Michael, et al.
Publicado: (2021)

Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B
por: Bittel, Daniel C., et al.
Publicado: (2022)

Evidence for Mitochondrial Respiratory Deficiency in Rat Rhabdomyosarcoma Cells
por: Jahnke, Vanessa E., et al.
Publicado: (2010)

Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury
por: Uaesoontrachoon, Kitipong, et al.
Publicado: (2013)

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy
por: Capogrosso, Roberta Francesca, et al.
Publicado: (2018)

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
por: Tatem, Kathleen S., et al.
Publicado: (2014)

Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit
por: Sreetama, Sen Chandra, et al.
Publicado: (2018)

Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion
por: Defour, A, et al.
Publicado: (2014)

The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse
por: Zhang, Aiping, et al.
Publicado: (2015)

Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype
por: Rayavarapu, Sree, et al.
Publicado: (2010)

Membrane Sealant Poloxamer P188 Protects Against Isoproterenol Induced Cardiomyopathy in Dystrophin Deficient Mice
por: Spurney, Christopher F, et al.
Publicado: (2011)

Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy
por: Heier, Christopher R, et al.
Publicado: (2019)

A mouse model of inherited choline kinase β-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia
por: Tavasoli, Mahtab, et al.
Publicado: (2022)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis
por: Coley, William, et al.
Publicado: (2013)

Loss of calpain3b in Zebrafish, a Model of Limb-Girdle Muscular Dystrophy, Increases Susceptibility to Muscle Defects Due to Elevated Muscle Activity
por: Prykhozhij, Sergey V., et al.
Publicado: (2023)

Mechanism of Ca(2+)-triggered ESCRT assembly and regulation of cell membrane repair
por: Scheffer, Luana L., et al.
Publicado: (2014)

OPN‐a induces muscle inflammation by increasing recruitment and activation of pro‐inflammatory macrophages
por: Many, Gina M., et al.
Publicado: (2016)

Effect of the IL-1 Receptor Antagonist Kineret(®) on Disease Phenotype in mdx Mice
por: Benny Klimek, Margaret E., et al.
Publicado: (2016)

Dysregulated calcium homeostasis prevents plasma membrane repair in Anoctamin 5/TMEM16E-deficient patient muscle cells
por: Chandra, Goutam, et al.
Publicado: (2019)

Deficiency of calpain-6 inhibits primary ciliogenesis
por: Kim, Bo Hye, et al.
Publicado: (2019)

Annexin A2 Mediates Dysferlin Accumulation and Muscle Cell Membrane Repair
por: Bittel, Daniel C., et al.
Publicado: (2020)

Calpains in cyanobacteria and the origin of calpains
por: Vešelényiová, Dominika, et al.
Publicado: (2022)

Elusive sources of variability of dystrophin rescue by exon skipping
por: Vila, Maria Candida, et al.
Publicado: (2015)

Comparison of the efficacy of second and third generation lentiviral vector transduced CAR CD19 T cells for use in the treatment of acute lymphoblastic leukemia both in vitro and in vivo models
por: Sawaisorn, Piamsiri, et al.
Publicado: (2023)

Calpain-2 Compensation Promotes Angiotensin II-Induced Ascending and Abdominal Aortic Aneurysms in Calpain-1 Deficient Mice
por: Subramanian, Venkateswaran, et al.
Publicado: (2013)

VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
por: Heier, Christopher R, et al.
Publicado: (2013)

Calpain-6 Deficiency Promotes Skeletal Muscle Development and Regeneration
por: Tonami, Kazuo, et al.
Publicado: (2013)

Calpain-2 participates in the process of calpain-1 inactivation
por: Shinkai-Ouchi, Fumiko, et al.
Publicado: (2020)

Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
por: Novak, James S., et al.
Publicado: (2018)

Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
por: Novak, James S., et al.
Publicado: (2018)

Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle
por: Novak, James S., et al.
Publicado: (2017)

Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle
por: Toral-Ojeda, Ivan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qmde6qmskcp35ktg3tbepvuaru